PTEN and ovarian endometrioid adenocarcinoma: Targeted deletion of PTEN has been used to modulate the initiation of HGSOC and endometrioid ovarian cancer (EOC) in mouse models [10–13], but it is unknown whether PTEN loss could initiate or drive the progression of HGSOC in humans.